FDA Inspection 977464 — Corden Pharma Colorado, Inc.

Corden Pharma Colorado, Inc. — FEI 1710165

The FDA completed an inspection of Corden Pharma Colorado, Inc. on Feb 12, 2016 in Boulder, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 12, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boulder, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.